APYX MEDICAL CORP (APYX) Stock Price, Quote, News and Overview
NASDAQ:APYX - Nasdaq - US03837C1062 - Common Stock - Currency: USD
APYX Quote, Performance and Key Statistics
1.54
-0.12 (-7.23%)
The current stock price of APYX is 1.54 USD. In the past month the price increased by 72.94%. In the past year, price decreased by -3.75%.
APYX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.47 | 228.44B | ||
| ISRG | INTUITIVE SURGICAL INC | 70.62 | 193.38B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.7 | 154.60B | ||
| SYK | STRYKER CORP | 30.06 | 143.93B | ||
| MDT | MEDTRONIC PLC | 14.67 | 103.48B | ||
| BDX | BECTON DICKINSON AND CO | 12.16 | 49.12B | ||
| EW | EDWARDS LIFESCIENCES CORP | 28.84 | 44.09B | ||
| IDXX | IDEXX LABORATORIES INC | 44 | 40.65B | ||
| RMD | RESMED INC | 26.74 | 35.61B | ||
| DXCM | DEXCOM INC | 51.22 | 33.14B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.03 | 31.67B | ||
| STE | STERIS PLC | 26.02 | 23.87B |
Related stock screener links
About APYX
Company Profile
Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 220 full-time employees. The firm's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. The company focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. The company specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.
Company Info
APYX MEDICAL CORP
5115 Ulmerton Rd
Clearwater FLORIDA 33760 US
CEO: Charles D. Goodwin II
Employees: 220
Phone: 18005372790
APYX MEDICAL CORP / APYX FAQ
What is the stock price of APYX MEDICAL CORP today?
The current stock price of APYX is 1.54 USD. The price decreased by -7.23% in the last trading session.
What is the ticker symbol for APYX MEDICAL CORP stock?
The exchange symbol of APYX MEDICAL CORP is APYX and it is listed on the Nasdaq exchange.
On which exchange is APYX stock listed?
APYX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for APYX MEDICAL CORP stock?
9 analysts have analysed APYX and the average price target is 4.08 USD. This implies a price increase of 164.94% is expected in the next year compared to the current price of 1.54. Check the APYX MEDICAL CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is APYX MEDICAL CORP worth?
APYX MEDICAL CORP (APYX) has a market capitalization of 58.20M USD. This makes APYX a Micro Cap stock.
How many employees does APYX MEDICAL CORP have?
APYX MEDICAL CORP (APYX) currently has 220 employees.
What are the support and resistance levels for APYX MEDICAL CORP (APYX) stock?
APYX MEDICAL CORP (APYX) has a support level at 0.92 and a resistance level at 1.65. Check the full technical report for a detailed analysis of APYX support and resistance levels.
Is APYX MEDICAL CORP (APYX) expected to grow?
The Revenue of APYX MEDICAL CORP (APYX) is expected to grow by 1.98% in the next year. Check the estimates tab for more information on the APYX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy APYX MEDICAL CORP (APYX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of APYX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of APYX, evaluating the profitability, health, valuation and growth aspects
- APYX MEDICAL CORP (APYX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- APYX MEDICAL CORP (APYX) Sales and EPS estimates to see what analysts future expectations are.
- APYX MEDICAL CORP (APYX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- APYX MEDICAL CORP (APYX) Insider and Institutional Ownership to learn about the owners and their transactions.
- APYX MEDICAL CORP (APYX) Stock Chart to make your own analysis
- APYX MEDICAL CORP (APYX) Latest news and press-releases to stay up to date.
Does APYX MEDICAL CORP (APYX) stock pay dividends?
APYX does not pay a dividend.
When does APYX MEDICAL CORP (APYX) report earnings?
APYX MEDICAL CORP (APYX) will report earnings on 2025-08-06, before the market open.
What is the Price/Earnings (PE) ratio of APYX MEDICAL CORP (APYX)?
APYX MEDICAL CORP (APYX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.55).
What is the Short Interest ratio of APYX MEDICAL CORP (APYX) stock?
The outstanding short interest for APYX MEDICAL CORP (APYX) is 0.81% of its float. Check the ownership tab for more information on the APYX short interest.
APYX Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to APYX. When comparing the yearly performance of all stocks, APYX turns out to be only a medium performer in the overall market: it outperformed 49.3% of all stocks.
APYX Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to APYX. APYX may be in some trouble as it scores bad on both profitability and health.
APYX Financial Highlights
Over the last trailing twelve months APYX reported a non-GAAP Earnings per Share(EPS) of -0.55. The EPS increased by 25.68% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.31% | ||
| ROE | -190.63% | ||
| Debt/Equity | 3.25 |
APYX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to APYX. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 40.12% and a revenue growth 1.98% for APYX